DBVT News and Press, DBV Technologies S.A. From 03/30/20

Montrouge, France, March 30, 2020 Ordinary and Extraordinary General Meeting of April 20, 2020 Procedures for Obtaining Preparatory Documents for the General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage b...

Montrouge, France, March 20, 2020 DBV Technologies Announces Filing of 2019 Universal Registration Document and 2019 Annual Report on Form 20-F DBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced the filing of its 2019 Universal Reg...

Waitr Holdings (NASDAQ: WTRH ) +70%  as few consumer stocks are performing well during the rough road ahead. More news on: Waitr Holdings Inc., iFresh Inc., Biomerica, Inc., Stocks on the move, , Read more ...

Biomerica (NASDAQ: BMRA ) +133%  on advancement of rapid coronavirus test. More news on: Biomerica, Inc., IMV Inc., Vaxart, Inc., Stocks on the move, , Read more ...

                      Monthly information regarding the total number of voting rights and  total number of shares of the Company as of February 29, 2020 and March 4, 2020 (Article 223-16 of the General Regulations of the ...

Gainers:  Sundance Energy (NASDAQ: SNDE ) +320% . More news on: Sundance Energy, Inc., BioNTech SE, Jiayin Group Inc., Stocks on the move, , Read more ...

DBV Technologies (NASDAQ: DBVT )  -50%  on hiccup with Viaskin Peanut . More news on: DBV Technologies S.A., GNC Holdings, Inc., Sasol Limited, Stocks on the move, , Read more ...

DBV Technologies (NASDAQ: DBVT ) craters  45%  premarket on increased volume in reaction to its announcement that the FDA, during its review of its marketing application for Viaskin Peanut, has identified "questions" about efficacy, including the impact of patch-site adhesion. ...

Montrouge, France, March 16, 2020 DBV Technologies Provides Update on Viaskin Peanut BLA for Children Ages 4-11 Years                    Conference call today, March 16, at 5:00 PM ET / 10:00 PM C...

Montrouge, France, February 24, 2020 DBV Technologies to Present Detailed Safety and Efficacy Data of Viaskin Peanut at AAAAI 2020 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced ...